- JP-listed companies
- MEDINET Co., Ltd.
- Financials
- Marketable securities, current
MEDINET Co., Ltd. (2370)
Market cap
¥7.9B
P/E ratio
-5.5x
Medinet develops cell processing and regenerative medicine products for hospitals and pharmaceutical companies, offering manufacturing services and facility operations.
| Period End | Marketable securities, current (Million JPY) | YoY (%) |
|---|---|---|
| Sep 30, 2025 | 1,000 | +11.11% |
| Sep 30, 2017 | 900 | -18.18% |
| Sep 30, 2016 | 1,100 | -31.25% |
| Sep 30, 2015 | 1,600 | -57.89% |
| Sep 30, 2014 | 3,800 |